Atovaquone; Proguanil Hydrochloride Patent Expiration

Atovaquone; Proguanil Hydrochloride is Used for treating protozoal infections. It was first introduced by Glaxosmithkline in its drug Malarone on Jul 14, 2000. Another drug containing Atovaquone; Proguanil Hydrochloride is Malarone Pediatric. 3 different companies have introduced drugs containing Atovaquone; Proguanil Hydrochloride.


Atovaquone; Proguanil Hydrochloride Patents

Given below is the list of patents protecting Atovaquone; Proguanil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Malarone US5998449

(Pediatric)

Combination of atovaquone with proguanil for the treatment of protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone US6166046

(Pediatric)

Combination of atovaquone with proguanil for the treatment of protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone US6291488

(Pediatric)

Preventing protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone Pediatric US5998449

(Pediatric)

Combination of atovaquone with proguanil for the treatment of protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone Pediatric US6166046

(Pediatric)

Combination of atovaquone with proguanil for the treatment of protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone Pediatric US6291488

(Pediatric)

Preventing protozoal infections May 25, 2014

(Expired)

Glaxosmithkline
Malarone US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline
Malarone US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline
Malarone US6291488 Preventing protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline
Malarone Pediatric US5998449 Combination of atovaquone with proguanil for the treatment of protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline
Malarone Pediatric US6166046 Combination of atovaquone with proguanil for the treatment of protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline
Malarone Pediatric US6291488 Preventing protozoal infections Nov 25, 2013

(Expired)

Glaxosmithkline



Atovaquone; Proguanil Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Atovaquone; Proguanil Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Atovaquone; Proguanil Hydrochloride. The first generic version for Atovaquone; Proguanil Hydrochloride was by Glenmark Pharmaceuticals Ltd and was approved on Jan 12, 2011. And the latest generic version is by Glenmark Pharmaceuticals Ltd and was approved on Apr 6, 2015.

Given below is the list of companies who have filed for Atovaquone; Proguanil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Atovaquone; Proguanil Hydrochloride. All of these versions come by the name ATOVAQUONE AND PROGUANIL HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG; 100MG

tablet Prescription ORAL AB Jan 12, 2011
62.5MG; 25MG

tablet Prescription ORAL AB Apr 6, 2015





2. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Atovaquone; Proguanil Hydrochloride. All of these versions come by the name ATOVAQUONE AND PROGUANIL HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
62.5MG; 25MG

tablet Prescription ORAL AB May 27, 2014
250MG; 100MG

tablet Prescription ORAL AB May 27, 2014


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Greensboro Mylan Pharmaceuticals Inc
Morgantown Mylan Specialty, L.P.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Saint Albans Mylan Technologies, Inc.
Rockford Mylan Institutional, Inc.
San Carlos Mylan Pharmaceuticals Inc.
India
Aurangabad Mylan Laboratories Limited (FDF-2)
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta